医学
甲状腺结节
细针穿刺
恶性肿瘤
活检
结核(地质)
放射科
厘米
甲状腺肿
甲状腺
外科
病理
内科学
生物
古生物学
作者
Rıfki Üçler,Celil Alper Usluoğulları,Abbas Ali Tam,Didem Özdemir,Fevzi Balkan,S. Yalçin,Gülten Kıyak,Pamir Eren Ersoy,Gülnur Güler,Reyhan Ersoy,Bekir Çakır
摘要
Whether under ultrasonography (US) guidance or not, fine-needle aspiration biopsy (FNAB) has some limitations, particularly in larger nodules. In this study, we aimed to evaluate the diagnostic value of US-guided fine-needle aspiration biopsy (US-FNAB) in thyroid nodules equal to or larger than 3 cm.Data of 267 patients operated for nodular goiter in the period of January 2006 and March 2012 were reviewed retrospectively. The study group (40 males, 104 females; mean age 42.3 ± 12.3, between 17 and 71) consisted of patients with nodules with a diameter of 3 cm or larger. Patients with nodules less than 3 cm in diameter were considered as the control group (27 males, 96 females; mean age 44.4 ± 11.9, between 18 and 71).For nodules smaller than 3 cm, US-FNAB had an accuracy rate of 60% and a false negativity rate of 21.9%. In nodules equal to or larger than 3 cm, the accuracy rate of US-FNAB was 80%, with a false negativity rate of 6.7%. Malignancy was observed in 16% of the study group and 42.3% of the control group.This study showed that increased nodule diameter is not associated with limitations in the diagnostic value of US-FNAB. We also found that the malignancy rate was smaller for larger nodules. This finding reflects the importance of accurate and rational diagnostic work-up and clinical management for detecting malignancy and surgical decision-making.
科研通智能强力驱动
Strongly Powered by AbleSci AI